0001415889-23-000766.txt : 20230110 0001415889-23-000766.hdr.sgml : 20230110 20230110211902 ACCESSION NUMBER: 0001415889-23-000766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230106 FILED AS OF DATE: 20230110 DATE AS OF CHANGE: 20230110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JORDAN ANDREW R CENTRAL INDEX KEY: 0001206350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 23522443 MAIL ADDRESS: STREET 1: C/O GUILFORD PHARMACEUTICALS INC STREET 2: 6611 TIBUTARY ST. CITY: BALTIMORE STATE: MD ZIP: 21224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 form4-01112023_020152.xml X0306 4 2023-01-06 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001206350 JORDAN ANDREW R C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341 false true false false CHIEF STRATEGY OFFICER Common Stock 2023-01-06 4 A 0 261718 0 A 913082 D Common Stock 2023-01-06 4 F 0 73940 0.7099 D 839142 D Represents shares of common stock granted under the Idera Pharmaceuticals, Inc. 2013 Stock Incentive Plan, as amended and restated. The shares were granted pursuant to that certain Employment Continuation and Retention Bonus Letter Agreement, dated as of September 28, 2022, between the Issuer and Reporting Person. Represents the number of shares withheld by Issuer to cover tax obligations in connection with the grant of the shares of common stock. /s/ John J. Kirby, Attorney-in-Fact 2023-01-10